Blood-Brain Barrier Disruption and Perivascular Beta-Amyloid Accumulation in the Brain of Aged Rats with Spontaneous Hypertension: Evaluation with Dynamic Contrast-Enhanced Magnetic Resonance Imaging |
Wang, Yu
(Department of Radiology, West China Hospital, Sichuan University)
Zhang, Ruzhi (Department of Radiology, West China Hospital, Sichuan University) Tao, Chuanyuan (Department of Neurosurgery, West China Hospital, Sichuan University) Xu, Ziqian (Department of Radiology, West China Hospital, Sichuan University) Chen, Wei (Department of Radiology, West China Hospital, Sichuan University) Wang, Chunhua (Department of Radiology, West China Hospital, Sichuan University) Song, Li (Department of Radiology, West China Hospital, Sichuan University) Zheng, Jie (Mallinckrodt Institute of Radiology, Washington University School of Medicine) Gao, Fabao (Department of Radiology, West China Hospital, Sichuan University) |
1 | Carnevale D, Mascio G, D'Andrea I, Fardella V, Bell RD, Branchi I, et al. Hypertension induces brain -amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension 2012;60:188-197 DOI |
2 | Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-154 DOI |
3 | Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med 2013;19:1584-1596 DOI |
4 | Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol 2002;38:323-337 DOI |
5 | Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57:173-185 DOI |
6 | Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008;57:178-201 DOI |
7 | Pelisch N, Hosomi N, Mori H, Masaki T, Nishiyama A. RAS inhibition attenuates cognitive impairment by reducing blood- brain barrier permeability in hypertensive subjects. Curr Hypertens Rev 2013;9:93-98 DOI |
8 | Ueno M, Sakamoto H, Tomimoto H, Akiguchi I, Onodera M, Huang CL, et al. Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats. Acta Neuropathol 2004;107:532-538 DOI |
9 | Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S. Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol 2008;18:240-252 DOI |
10 | Gentile MT, Poulet R, Di Pardo A, Cifelli G, Maffei A, Vecchione C, et al. Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension. Neurobiol Aging 2009;30:222-228 DOI |
11 | Schreiber S, Drukarch B, Garz C, Niklass S, Stanaszek L, Kropf S, et al. Interplay between age, cerebral small vessel disease, parenchymal amyloid-, and tau pathology: longitudinal studies in hypertensive stroke-prone rats. J Alzheimers Dis 2014;42 Suppl 3:S205-S215 DOI |
12 | Bhatia R, Lin H, Lal R. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB J 2000;14:1233-1243 DOI |
13 | Bell RD, Zlokovic BV. Neurovascular mechanisms and bloodbrain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009;118:103-113 DOI |
14 | Bailey EL, Wardlaw JM, Graham D, Dominiczak AF, Sudlow CL, Smith C. Cerebral small vessel endothelial structural changes predate hypertension in stroke-prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5- to 21-week-old rats. Neuropathol Appl Neurobiol 2011;37:711-726 DOI |
15 | Bueche CZ, Hawkes C, Garz C, Vielhaber S, Attems J, Knight RT, et al. Hypertension drives parenchymal -amyloid accumulation in the brain parenchyma. Ann Clin Transl Neurol 2014;1:124-129 DOI |
16 | Csiszar A, Tucsek Z, Toth P, Sosnowska D, Gautam T, Koller A, et al. Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in -amyloid generation and Alzheimer's disease. Am J Physiol Heart Circ Physiol 2013;305:H1120-H1130 DOI |
17 | Faraco G, Park L, Zhou P, Luo W, Paul SM, Anrather J, et al. Hypertension enhances -induced neurovascular dysfunction, promotes -secretase activity, and leads to amyloidogenic processing of APP. J Cereb Blood Flow Metab 2016;36:241-252 DOI |
18 | Aksoy D, Bammer R, Mlynash M, Venkatasubramanian C, Eyngorn I, Snider RW, et al. Magnetic resonance imaging profile of blood-brain barrier injury in patients with acute intracerebral hemorrhage. J Am Heart Assoc 2013;2:e000161 |
19 | Zhang H, Ma Q, Zhang YW, Xu H. Proteolytic processing of Alzheimer's -amyloid precursor protein. J Neurochem 2012;120 Suppl 1:9-21 DOI |
20 | Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 2015;85:296-302 DOI |
21 | Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 2003;9:907-913 DOI |
22 | Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232 DOI |
23 | Ortuno JE, Ledesma-Carbayo MJ, Simoes RV, Candiota AP, Arus C, Santos A. DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data. BMC Bioinformatics 2013;14:316 DOI |
24 | Heye AK, Culling RD, Valdes Hernandez Mdel C, Thrippleton MJ, Wardlaw JM. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Neuroimage Clin 2014;6:262-274 DOI |
25 | Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 6th ed. San Diego: Elsevier Academic Press, 2007:273-275 |
26 | Nag S. Immunohistochemical detection of endothelial proteins. Methods Mol Med 2003;89:489-501 |
27 | Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353-356 DOI |
28 | Nicolas M, Hassan BA. Amyloid precursor protein and neural development. Development 2014;141:2543-2548 DOI |
29 | Wang W, Mutka AL, Zmrzljak UP, Rozman D, Tanila H, Gylling H, et al. Amyloid precursor protein - and -cleaved ectodomains exert opposing control of cholesterol homeostasis via SREBP2. FASEB J 2014;28:849-860 DOI |